Search clinical trials for: Target Lesion Revascularization (TLR)

Total 38453 results

Masonic Cancer Center, University of Minnesota
Pfizer

Completed

Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers

Cervical Cancer | Breast Cancer | Ovarian Cancer | Endometrial Cancer

United States
Hisar Intercontinental Hospital

Completed

Testicular Torsion

Testicular Torsion and TLR 4 Was Investigated
Eikon Therapeutics
Merck Sharp & Dohme LLC

Active, not recruiting

Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Tumor, Solid

United States
Eikon Therapeutics
Seven and Eight Biopharmaceuticals Inc

Active, not recruiting

BDB001-102: Open Label Dose Escalation of BDB001 in Combination w Atezolizumab

Tumor, Solid

United States
Aristotle University Of Thessaloniki

Unknown

The Role of TLR-4 Polymorphisms in Children With Urinary Track Infections (TLR-4)

Urinary Tract Infection

Greece
Eikon Therapeutics
Seven and Eight Biopharmaceuticals Inc

Completed

BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid Tumors

Tumor, Solid

United States
Eikon Therapeutics
Merck Sharp & Dohme LLC

Active, not recruiting

BDB001-101: Clinical Study of BDB001 as a Mono-therapy or in Combination With Pembrolizumab

Tumor, Solid

United States
University of Southern Denmark
Danish Cancer Society

Completed

Diet, Genes and Colorectal Cancer - With Focus on Toll-like Receptor Polymorphisms

Colorectal Cancer
Helsinki University Central Hospital

Completed

Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis (Dialysis Fistulae) (DRECOREST2)

Vascular Access Complication | Restenosis, Vascular Graft | Dialysis Related Complications
University of Turin, Italy

Unknown

TLR Polymorphism, ASO and Beta-hemolytic Group A Streptococcus Infections in ADHD: an Observational Study (TLR;)

Attention Deficit-Hyperactivity Disorder

Italy
Eli Lilly and Company

Completed

A Study in Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Radboud University Medical Center

Completed

Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients

Melanoma

Netherlands
Sudhalkar Eye Hospital

Completed

TLR-9 Antagonism in Steroid Resistant Optic Neuritis

Optic Neuritis

India
University of Thessaly

Unknown

Bacteremia in Intensive Care Unit (ICU)

Bacteremia and Sepsis | Toll-Like-Receptors (TLRs)

Greece
Asociacion para el Estudio de las Enfermedades...
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon...

Completed

Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome (Resistir)

Cytokine Release Syndrome | Disease, Viral | TLRs

Spain
MedImmune LLC

Terminated

A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors

Cancer | Solid Tumors | CTCL

United States, France, Canada
M.D. Anderson Cancer Center

Completed

Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist

Melanoma

United States
Gilead Sciences

Completed

Study To Evaluate Safety and Efficacy of Vesatolimod for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Participants

Chronic Hepatitis B

Canada, United States, Korea, Republic of, Italy, Netherlands, New Zealand
Marco Alexandre Dias da Rocha
Bayer; Associacao Fundo de Incentivo a Psicofarmcologia; Fleury

Unknown

The Influence of Peripheral Androgen Conversion at Women Adult Acne

Quality of Life | Acne

Brazil
University of Maryland, Baltimore

Withdrawn

TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B (BOOST-9)

Hepatitis B

United States
University of British Columbia

Completed

Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists

Influenza Vaccination in Seniors

Canada
Medicines for Malaria Venture
Shin Poong Pharmaceutical Co. Ltd.

Completed

Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria

Plasmodium Falciparum Malaria

Cambodia, Gambia, Indonesia, Senegal, Thailand, Uganda
National Cardiovascular Center Harapan Kita Hospital...

Completed

Prognostic Value of NLR, TLR, and ALC in Predicting ToF Primary Repair Outcome

Tetralogy of Fallot | Congenital Heart Disease | Outcome | TOF | Neutrophil-lymphocyte Ratio | Absolute Lymphocyte Count | Thrombocyte-lymphocyte Ratio

Indonesia
Radboud University Medical Center

Completed

Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients

Melanoma

Netherlands
Joachim Aerts, MD PhD
AIM ImmunoTech Inc.; AstraZeneca BV

Recruiting

Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy (DURIPANC)

Metastatic Pancreatic Cancer

Netherlands
M.D. Anderson Cancer Center
Mologen AG

Active, not recruiting

Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies

Melanoma | Advanced Cancers

United States
Sumitomo Pharma America, Inc.
Syneos Health

Terminated

A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile

Neoplasms

United States
Craig L Slingluff, Jr
University of Virginia

Completed

Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists (MEL60)

Melanoma | Metastatic Melanoma | Mucosal Melanoma

United States
University of Adelaide

Unknown

The Progression From Dysmenorrhoea to Chronic Pelvic Pain

Chronic Pain | Pelvic Pain | Dysmenorrhoea

Australia
Tanta University

Completed

Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Egypt
NYU Langone Health
National Cancer Institute (NCI)

Completed

Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases

Breast Cancer | Metastatic Breast Cancer | Recurrent Breast Cancer

United States
Medtronic Vascular

Completed

Resolute Integrity US Extended Length Sub-Study(RI US XL) (RI-US XL)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System (RI-US)

Coronary Artery Disease

United States
Kaohsiung Medical University Chung-Ho Memorial...
Centers for Disease Control and Prevention

Unknown

Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection

Dengue Fever

Taiwan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema

Cirrhosis

Japan
Gilead Sciences

Completed

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Hepatitis B

Korea, Republic of, United States, Canada, Australia, New Zealand
Gilead Sciences

Completed

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Hepatitis B | HBV

Korea, Republic of, United States, Canada, Australia, New Zealand
National Institute of Allergy and Infectious Diseases...
Korean Center for Disease Control and Prevention; International Tuberculosis... and other collaborators

Completed

Multi-Drug Resistant Tuberculosis in Korea

Tuberculosis

Korea, Republic of
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

Intratumoral Tilsotolimod, a TLR-9 Agonist, Together With Intratumoral Ipilimumab and Intravenous Nivolumab in Patients With Advanced Cancers (PRIMO)

Advanced Cancer

France
Medtronic Vascular

Completed

RESOLUTE China Registry: (R-C Registry)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Medtronic Vascular

Completed

RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia (R-A)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Coronary Stenosis

India
Medtronic Vascular

Completed

The Medtronic RESOLUTE US Clinical Trial (R-US)

Coronary Artery Disease

United States
Medtronic Vascular
Medtronic Japan Co., Ltd.

Completed

RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent (RJ)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Japan
Ludwig Institute for Cancer Research
Celgene; Cancer Research Institute, New York City; MedImmune LLC

Completed

Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer

Ovarian Cancer

United States, Switzerland
Dynavax Technologies Corporation

Completed

Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC

Advanced Non Small Cell Lung Cancer

United States
Craig L Slingluff, Jr
Celldex Therapeutics

Active, not recruiting

Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma) (Mel66)

Melanoma | Ocular Melanoma | Uveal Melanoma

United States
Medtronic Vascular

Completed

China Resolute Integrity 34/38 mm Study

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Celgene

Terminated

A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer

Carcinoma, Squamous Cell

United States
G. Hatzikosta General Hospital
University of Ioannina

Completed

Inflammatory Response in Laparoscopic and Open Colectomy

Colorectal Cancer

Greece
Medtronic Vascular

Active, not recruiting

RESOLUTE ONYX China Single Arm Study

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China

Search clinical trials for: Target Lesion Revascularization (TLR)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations